tadalafil 5 MG [clnd]
Once daily [tmco]
treatment [ftcn]
Erectile dysfunction [dsyn]
Observational Study [resa]
IMPACT [gngm]
Characteristics [qlco]
Comorbidities [idcn]
IMPACT [gngm]
Characteristics [qlco]
Relevant [qlco]
Comorbidities [idcn]
treatment [ftcn]
Effectiveness [qlco]
Satisfaction [menp]
Patients [podg]
Erectile dysfunction [dsyn]
Started [qlco]
Switch [mnob]
tadalafil 5 MG [clnd]
Once daily [tmco]
TAD [topp]
baseline [bodm]
Methods [inpr]
Observational Study [resa]
Phosphodiesterase 5 inhibitor [phsu]
Erectile dysfunction [dsyn]
Patients [podg]
Started [qlco]
Switch [mnob]
TAD [topp]
months [tmco]
Discontinuation [hlca]
TAD [topp]
Estimated [qnco]
Product-Limit Method [qnco]
months [tmco]
subgroups [virs]
Stratified [qlco]
Age [orga]
Phosphodiesterase 5 inhibitor [phsu]
Pretreatment [sbst]
Erectile dysfunction [dsyn]
Severity [qlco]
mild moderate [qlco]
Severe [qlco]
absence [qnco]
Relevant [qlco]
Comorbidities [idcn]
BPH [patf]
Diabetes [dsyn]
CVD, NOS [dsyn]
Hypertension [dsyn]
Dyslipidaemia [dsyn]
baseline [bodm]
International index of erectile function [inpr]
Erectile dysfunction [dsyn]
Inventory [mnob]
Treatment satisfaction [fndg]
Scores [qnco]
Cis [euka]
Assessed [acty]
Mixed [ftcn]
repeated measures [resa]
Visit [bhvr]
Erectile dysfunction [dsyn]
aetiology [ftcn]
subgroups [virs]
included [ftcn]
Fixed [fndg]
effects [qlco]
Patients [podg]
Received [qlco]
Prescriptions [hlca]
Initiate [idcn]
Switch [mnob]
TAD [topp]
baseline [bodm]
>90 [qnco]
Patients [podg]
TAD [topp]
Aged [orga]
Patients [podg]
SEVERE DYSFUNCTION [fndg]
Erectile [ortf]
Patients [podg]
subgroups [virs]
Aged [orga]
Continued [idcn]
TAD [topp]
Negative [qlco]
International index of erectile function score [clna]
Domain [ftcn]
Improvement [cnce]
BPH [patf]
P NOS [aapp, imft]
0.014" [qnco]
Previous [tmco]
Phosphodiesterase 5 inhibitor [phsu]
treatment [ftcn]
P NOS [aapp, imft]
Mild [qlco]
MODERATE DYSFUNCTION [fndg]
Erectile [ortf]
P NOS [aapp, imft]
Possibly [qlco]
Link [inpr]
bigger [qnco]
Treatment Effect [fndg]
With [qlco]
SEVERE DYSFUNCTION [fndg]
Erectile [ortf]
baseline [bodm]
International index of erectile function [inpr]
Diabetes [dsyn]
P NOS [aapp, imft]
most likely [idcn]
Diabetes [dsyn]
SEVERE DYSFUNCTION [fndg]
Erectile [ortf]
baseline [bodm]
Parameters [fndg]
statistically significant [qnco]
effects [qlco]
International index of erectile function [inpr]
Observed [ftcn]
Comorbidity [idcn]
baseline [bodm]
Age [orga]
P NOS [aapp, imft]
Affected [ftcn]
In [qnco]
Erectile dysfunction [dsyn]
Inventory [mnob]
Treatment satisfaction [fndg]
Conclusions [idcn]
Routine [qlco]
condition [dsyn]
treatment [ftcn]
Satisfaction [menp]
Affected [ftcn]
Comorbidities [idcn]
Men [popg]
Choose [acty]
Erectile dysfunction [dsyn]
treatment [ftcn]
TAD [topp]
magnitude [qnco]
Treatment Effectiveness [qlco]
Affected [ftcn]
Certain [qlco]
baseline [bodm]
Characteristics [qlco]
Co-morbid conditions [fndg]
